Bartter syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:112OMIM:241200E26.8
Who is this for?
Show terms as
18Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Bartter syndrome is a group of rare inherited renal tubular disorders characterized by impaired salt reabsorption in the thick ascending limb of the loop of Henle in the kidneys. This leads to a distinctive set of metabolic abnormalities including hypokalemia (low potassium), hypochloremic metabolic alkalosis (elevated blood pH with low chloride), hyperreninemia, and hyperaldosteronism with normal to low blood pressure. The condition primarily affects the kidneys but has widespread consequences for the cardiovascular, muscular, and skeletal systems. Several subtypes of Bartter syndrome have been identified (types I through V), each caused by mutations in different genes involved in ion transport in the kidney. Type I is caused by mutations in SLC12A1 (encoding the NKCC2 cotransporter), type II by KCNJ1 (ROMK potassium channel), type III by CLCNKB (chloride channel Kb), type IVa by BSND (barttin), type IVb by combined CLCNKA and CLCNKB mutations, and type V by MAGED2 mutations. The antenatal/neonatal forms (types I, II, IV, and V) typically present with polyhydramnios, premature birth, life-threatening salt and water loss, polyuria, and failure to thrive. Type III, also known as classic Bartter syndrome, generally presents in infancy or early childhood with less severe symptoms including growth retardation, muscle weakness, cramps, fatigue, and salt craving. Some subtypes, particularly type IV, may also be associated with sensorineural deafness. Treatment is supportive and aimed at correcting electrolyte imbalances and minimizing complications. This typically includes potassium and magnesium supplementation, nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin to reduce renal prostaglandin production and improve electrolyte reabsorption, and potassium-sparing diuretics such as spironolactone or amiloride. ACE inhibitors may also be used in some cases. With appropriate lifelong management, many patients can achieve improved growth and quality of life, though careful monitoring of renal function and electrolytes remains essential.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Bartter syndrome.

View clinical trials →

No actively recruiting trials found for Bartter syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Bartter syndrome community →

Specialists

18 foundView all specialists →
PS
Pranjal Sharma
CUYAHOGA FALLS, OH
Specialist
1 Bartter syndrome publication
RQ
Rakhtan K Qasba
Specialist
1 Bartter syndrome publication
AB
Akshat Banga
CAMBRIDGE, MA
Specialist
1 Bartter syndrome publication
BK
Balakrishnan Kamaraj
Specialist
1 Bartter syndrome publication
FN
Faisal A Nawaz
Specialist
1 Bartter syndrome publication
HK
Harshadayani Jagadish Kumar
Specialist
1 Bartter syndrome publication
NC
Naye Choi
Specialist
2 Bartter syndrome publications
HK
Hee Gyung Kang
Specialist
2 Bartter syndrome publications
MH
Marguerite Hureaux
Specialist
2 Bartter syndrome publications
EL
Emre Leventoğlu
Specialist
2 Bartter syndrome publications
BB
Bahar Büyükkaragöz
Specialist
2 Bartter syndrome publications
DD
Demet Teker Düztaş
Specialist
2 Bartter syndrome publications
&G
Ödül Eğritaş Gürkan
Specialist
2 Bartter syndrome publications
DM
David H Ellison, MD
Specialist
PI on 1 active trial
MP
Maria Victoria Ferreira Piccoli
Specialist
1 Bartter syndrome publication
AB
Anna Carolina Flumignan Bucharles
Specialist
1 Bartter syndrome publication
SM
Sharon S Moe, MD
INDIANAPOLIS, IN
Specialist
PI on 1 active trial
FA
Farahnak Assadi
CHICAGO, IL
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Bartter syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Bartter syndromeForum →

No community posts yet. Be the first to share your experience with Bartter syndrome.

Start the conversation →

Latest news about Bartter syndrome

No recent news articles for Bartter syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Bartter syndrome

What is Bartter syndrome?

Bartter syndrome is a group of rare inherited renal tubular disorders characterized by impaired salt reabsorption in the thick ascending limb of the loop of Henle in the kidneys. This leads to a distinctive set of metabolic abnormalities including hypokalemia (low potassium), hypochloremic metabolic alkalosis (elevated blood pH with low chloride), hyperreninemia, and hyperaldosteronism with normal to low blood pressure. The condition primarily affects the kidneys but has widespread consequences for the cardiovascular, muscular, and skeletal systems. Several subtypes of Bartter syndrome have b

How is Bartter syndrome inherited?

Bartter syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Bartter syndrome?

18 specialists and care centers treating Bartter syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.